Your mission You will work on drug discovery projects to characterize drug-target protein interactions with drug candidates from our customers and from Proteros' own development projects. In collaboration with our lab managers, you will develop biochemical, cellular, and biophysical assays to characterize drug-target protein interactions. You will use biophysical technologies such as SPR, nanoDSF, MST, ITC, and enzymatic assays. You will perform robot-assisted drug screens. You will document your work steps and analyze the data according to our internal regulations and our customers' specifications. Your profile You have completed your master's/bachelor's degree in biology or biochemistry or your training as a CTA/MTA/BTA or chemistry/biology laboratory assistant with good results (no doctorate). You have practical experience in the field of biochemical and biophysical assays. You demonstrate great care and organizational skills when working on multiple projects simultaneously. You are characterized by your ability to work independently, your team spirit, your willingness to communicate, your service orientation, and your interest in learning new methods. You have good MS Office and English skills. Why us? An innovative professional field in anexciting industry An inspiring working atmosphere asfertile ground for your furtherdevelopment A comprehensive induction thatprepares you optimally for your areaof responsibility Multicultural teams and an opencorporate culture Contact Details Proteros biostructures GmbH People Team Bunsenstr. 7a, 82152 Martinsried 49 89 700761-0 joinus@proteros.de About us Proteros is a privately held early-stage services provider in structure-based drug discovery with a cutting-edge discovery engine tailored to unlock even the most technically challenging targets. Proteros’ work is built on scientific excellence and supports its clients to reach the right results and accelerate their overall research timelines. Proteros supports most of the world’s 20 largest pharma companies and more than 250 pharmaceutical and biotech partners in the US, Europe and Japan.